HIV & Inflammation
Research Study
Join a University of Pennsylvania research program testing a treatment that may improve attention and concentration in people living with HIV
HIV & Inflammation
Research Study
Join a University of Pennsylvania research program testing a treatment that may improve attention and concentration in people living with HIV
Philadelphia, PA
Compensation
Provided
7 Month Study
Living with HIV
30 Years and Older
Fast Facts
About this research study:
Partner with researchers as they learn more about a medication that may improve inflammation in people living with HIV and enhance attention and coordination.
Galantamine is a medication that has been approved by the FDA for improving memory and attention. The main purpose of this research study is to see if the medication improves memory and attention in people living with HIV.

If enrolled in this study, you may benefit from the knowledge that you are contributing in an important way to increasing scientific knowledge about neurocognitive disease and ways to improve its treatment in people living with HIV.
Additional Information